GlioCure will participate for the 2nd consecutive year in the business convention entirely dedicated to the oncology Meet2Win which will be held on 11 and 12 May 2017 in Bordeaux.
On this occasion Claire-Lépinoux Chambaud, GlioCure's R & D manager, will present the latest preclinical advances obtained with GC01 in the treatment of glioblastoma to the International Board of MATWIN, made up of academic and industrial opinion leaders in oncology.